Prism Medico & Pharmacy Appoints Mr. Harpreet Singh as Internal Auditor for FY 2025-2026
Prism Medico & Pharmacy Limited's Board of Directors, at their meeting held on May 11, 2026, approved the appointment of Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditor for the financial year 2025-2026. The board meeting commenced at 04:00 P.M. and concluded at 04:30 P.M. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Harpreet Singh, who has been in practice since 2018, is an associate member of the Institute of Chartered Accountants of India with expertise in direct tax, assurance, and accounting.
*this image is generated using AI for illustrative purposes only.
Prism Medico & Pharmacy Limited has announced the appointment of Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as its internal auditor for the financial year 2025-2026. The decision was taken at a Board of Directors meeting held on May 11, 2026, and disclosed to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board Meeting Details
The board meeting during which the appointment was approved was held at the company's registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh. The key details of the meeting and the appointment are summarised below:
| Parameter: | Details |
|---|---|
| Meeting Date: | May 11, 2026 |
| Meeting Commencement: | 04:00 P.M. |
| Meeting Conclusion: | 04:30 P.M. |
| Appointment: | Internal Auditor |
| Appointee: | Mr. Harpreet Singh |
| Firm Name: | M/s. S Harpreet and Associates, Chartered Accountants |
| Applicable Period: | Financial Year 2025-2026 |
| Regulatory Disclosure: | Regulation 30, SEBI (LODR) Regulations, 2015 |
The disclosure was signed by Davender Singh, Director (DIN: 09447213) of Prism Medico & Pharmacy Limited.
About the Appointed Auditor
Mr. Harpreet Singh is the proprietor of M/s. S Harpreet and Associates, Chartered Accountants, based in Derabassi, Punjab. He is a graduate and an associate member of the Institute of Chartered Accountants of India and has been in practice since 2018. The firm itself was established in 2019.
Mr. Harpreet Singh's areas of expertise include:
- Direct Tax
- Assurance and Accounting
- Internal Audits and Risk-Based Management Audits
- Tax Strategy and Compliance
About M/s. S Harpreet and Associates
M/s. S Harpreet and Associates offers a broad range of professional services to domestic and global businesses. The firm's service portfolio spans multiple disciplines, as outlined below:
| Service Area: | Key Offerings |
|---|---|
| Audit and Assurance: | Statutory Audits, Tax Audits, Internal Audits, Inspection and Investigation Audits |
| Tax and Regulatory: | Tax Planning, Compliance, Representation, International Taxation, Transfer Pricing |
| Indirect Tax: | GST Advisory, Custom-related Advisory Services |
| Corporate Law Services: | Incorporation, Statutory Filings, Corporate Litigation Support |
| Finance and Accounting Outsourcing: | Accounting Processes, Client Reporting |
| Corporate Finance: | Fund Raising, Business Valuation, Intangible Valuation |
The firm emphasises core values including integrity, competence, professionalism, responsibility and accountability, simplicity, adaptability, and versatility in its service delivery.
Historical Stock Returns for Prism Medico & Pharmacy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.99% | +0.80% | +4.91% | +50.93% | +119.46% | +191.76% |
How might the appointment of a relatively young firm (established 2019) as internal auditor impact investor confidence in Prism Medico & Pharmacy's governance standards compared to industry peers?
Could this internal audit appointment signal Prism Medico & Pharmacy's preparation for a broader compliance overhaul or potential fundraising activity in the near future?
What are the potential risks to Prism Medico & Pharmacy if M/s. S Harpreet and Associates, given its limited operational history, identifies significant internal control weaknesses during FY 2025-2026?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
